FRANCE – Coave Therapeutics, a clinical-stage biotechnology company, has received funding worth US$39m from eureKARE , a pioneering new company focused on financing and building next generation biotechnology companies, during…
Read MoreFRANCE – Coave Therapeutics, a clinical-stage biotechnology company, has received funding worth US$39m from eureKARE , a pioneering new company focused on financing and building next generation biotechnology companies, during…
Read More